Arcadia Biosciences, Inc. — Form D

Arcadia Biosciences, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-27. The offering totals $6.0M, of which $2.1M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Albert D. BollesDirectorDallas, TX
Deborah D. CarosellaDirectorDallas, TX
Kevin J. ComcowichDirectorDallas, TX
Thomas J. SchaeferDirectorDallas, TX
Gregory D. WallerDirectorDallas, TX
Amy D. YoderDirectorDallas, TX
Thomas J. SchaeferExecutive OfficerDallas, TX
Mark WongDirectorColumbus, OH
Amy YoderRelated PersonDallas, TX
Kevin ComcowichRelated PersonDallas, TX
David CollierDirectorSunnyvale, CA
Kevin T ComcowichDirectorDavis, CA
Albert D BollesDirectorDavis, CA
Lilian Shackelford MurrayDirectorDallas, TX
Lilian Shackelford MurrayRelated PersonDallas, TX
Gregory D WallerDirectorDallas, TX
Gregory D WallerRelated PersonDallas, TX
Amy D YoderDirectorDavis, CA
Matthew T PlavanDirectorDavis, CA
Matthew T PlavanExecutive OfficerDavis, CA
Pam T HaleyExecutive OfficerDavis, CA
Eric ReyExecutive OfficerSeattle, WA
Uday T GargDirectorDavis, CA
Rajendra T KetkarDirectorDavis, CA
Rajendra T KetkarExecutive OfficerDavis, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2026-06-26D$11.4M$4.0M
2021-02-16D$25.0M$25.0M
2018-04-11D$10.0M$10.0M
2014-04-25D$35.5M$18.9M
2009-11-25D$12.0M$2.4M
2009-08-04D$15.2M$15.2M

More